Antiviral and Monoclonal Antibody Combination Therapy in Haematological Patients in the Omicron Era

Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024043. doi: 10.4084/MJHID.2024.043. eCollection 2024.

¹ National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS-Rome Italy.
² North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.

No abstract available

Keywords: Antivirals; Immunocompromised; Monoclonal antibodies; Persistent infection; SARS-CoV-2 infection; Viral evolution.